Abu Dhabi acquires new antibody treatment to fight Covid-19

Known as Regen-Cov in the US, the cocktail is part of a new wave of therapies that 'jump-start' the immune system

Dr Jamal Al Kaabi, undersecretary of the Department of Health – Abu Dhabi, said the new drug would further equip the emirate to protect its population. Photo: Victor Besa / The National

A new therapy that helps the body fight off Covid-19 will be available for use in Abu Dhabi following a deal between health authorities and Swiss drug maker Roche.

The monoclonal antibody cocktail of casirivimab and imdevimab - known as Regen-Cov in some markets – has been given to people with Covid-19 who are likely to develop severe symptoms.

“Today, we have taken a significant step towards improving healthcare services in Abu Dhabi," said Dr Jamal Al Kaabi, undersecretary of the Department of Health – Abu Dhabi.

The deal will help efforts to "build a robust life science hub and spearhead the latest advancements for Covid-19 prevention and treatment", he said.

Roche has told US regulators the therapy can also be given to non-patients to protect them from potential coronavirus infection, including people with health conditions and those who are not fully vaccinated.

The US Food and Drug Administration approved Regen-Cov for emergency use in August but stressed it was "not a substitute for vaccination against Covid-19".

The Abu Dhabi and Roche deal will lead to further "real-world evidence generation" and research, authorities said, and is the latest step in helping the capital to build its life science industry.

The agreement further expands the arsenal of treatments that can be given to patients with mild, moderate and severe Covid-19 symptoms.

The anti-viral drug sotrovimab has been given to thousands of patients in the emirate. Early results showed that 97 per cent of recipients fully recovered within 14 days.

Indian students apply the finishing touches to paintings created to raise awareness of the variant in Mumbai. Reuters

International travellers wearing personal protective equipment arrive at Melbourne's Tullamarine Airport as Australia records its first cases of the Omicron variant. AFP

A greeting at the international terminal of Sydney Airport, as countries respond to the new variant. Reuters

A sign asking people to wear face coverings in a building in Manhattan as the newly discovered Omicron variant appears in countries around the world. AFP

Tourists wave as the ‘Europa’ passenger liner arrives in South African waters off Cape Town as the new coronavirus variant Omicron spreads in other countries. Reuters

Schiphol airport in Amsterdam. Dutch health authorities said they have found another case of the Omicron Covid-19 variant among passengers arriving from South Africa, bringing the country’s total to 14. AFP

Pupils wear face masks in Beijing. Despite the global worry, scientists say it remains unclear whether the Omicron variant is more dangerous than other strains of the virus. AP

People wearing face masks in Manhattan. New York's governor has declared a state of emergency due to the risk of a surge of Covid-19 cases as winter sets in. AFP

British Health Secretary Sajid Javid meets a member of staff at a vaccine centre in Guy's and St Thomas' Hospital, London. Getty Images

A sign points the way to a Covid-19 test centre at Schiphol Airport in the Netherlands. AFP

Narita International Airport in Japan is quiet after travel was restricted to prevent the spread of Omicron. Reuters

A PCR test at O.R. Tambo International Airport in Johannesburg. AFP

Soekarno Hatta International airport. Indonesia has banned the arrival of travellers who have recently been in eight southern African countries. Reuters

Suvarnabhumi Airport in Bangkok after Thailand banned entry from eight southern African countries due to the Omicron variant. Reuters

Travellers wear personal protective equipment outside the international terminal at Sydney Airport, Australia. Reuters

Passengers wearing protective gear at Incheon International Airport in South Korea, where health authorities have imposed an entry ban on foreign arrivals from eight African countries, including South Africa. EPA

Ben Gurion International Airport near Tel Aviv. The Israeli government approved a 14-day ban on foreign arrivals over concerns about Omicron. EPA

Travellers queuing in the hope of boarding an overbooked Lufthansa flight at Cape Town International Airport. Antonie Robertson / The National

Covid-stricken Czech President Milos Zeman sits in a plastic cage as he appoints Petr Fiala as Prime Minister, near Prague. AFP

Tourists checking in at Cape Town International Airport in South Africa. Antonie Robertson / The National

Several airlines have stopped flying out of South Africa amid the spread of the new variant, causing disruption at O.R. Tambo International Airport in Johannesburg. Reuters

Australian Health Minister Greg Hunt at a press conference at Parliament House in Canberra. Two cases of the recently discovered Omicron variant were detected in New South Wales. EPA

Passengers, many not wearing face coverings, on the London Underground. Health Secretary Sajid Javid said mandatory mask-wearing would return to shops and public transport in England but there are concerns over how the rule will be enforced. AFP

A stroll, with face masks, in Biarritz, south-western France. French Health Minister Olivier Veran said France had no confirmed cases of the Omicron variant and was not changing its strategy of increasing vaccinations and booster shots. AP

British Prime Minister Boris Johnson and Chief Medical Officer Chris Whitty during a press conference on the variant in London. Reuters

Jump starting the immune system

A study by Roche partner Regeneron said the cocktail cut the risk of getting covid-19 by 82 per cent for up to eight months. It is part of a new generation of therapies that "jump-start" the immune system’s fight against the virus.

Jointly run with the National Institute of Allergy and Infectious Diseases, the study enrolled people who lived in a household with someone diagnosed with Covid within the previous four days.

Earlier results from the trial showed the treatment cut the risk of infection by 81 per cent within the first month, Bloomberg reported earlier this month. The new data shows the protection was maintained, with an 82 per cent reduction in symptomatic infections for as long as eight months after the therapy was administered.

During the study, none of the people in the treatment group were admitted to hospital due to Covid, compared with six people in the placebo group. No deaths stemming from Covid infection occurred in either group.